Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Innovent Medical Solutions Ltd.

Latest From Innovent Medical Solutions Ltd.

Hospital-Acquired Conditions: Patient Safety Concerns Fuel Device Innovation

New federal initiatives to improve patient safety are taking direct aim at hospitals' bottom line by making them bear the increased costs of treatment when patients acquire a condition deemed reasonably preventable. At this year's meeting of the Association of Operating Room Nurses, companies showcased new technologies designed to help hospitals avoid so-called "never events" like leaving objects in a patient after surgery, pressure ulcers acquired during a patient's stay, and certain nosocomial infections.
Medical Device

Start-Up News March 2008

Noteworthy news from medtech start-ups, including Angel Medical's implantable early warning system for heart attacks and Innovent Medical's non-invasive device to prevent ventilator-associated pneumonia in the ICU.
Medical Device

Start-Up Previews (6/07)

A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group: A New Perspective on Cancer Immunotherapy, features profiles of Apthera, Juvaris BioTherapeutics, Pique Therapeutics and Vaxon. Plus these Start-Ups Across Health Care: Acceleron Pharma, CTG Pharma, ImVisioN, and Innovent Medical.

Innovent Medical Solutions Ltd.

Ventilator associated pneumonia (VAP), the second most common infection in the ICU, is caused when infected secretions that accumulate in and around the endotracheal tube leak into the lungs. Innovent Medical Solutions Ltd. intends to reduce both the incidence and the cost of treating VAP with noninvasive technology that mimics nature's own method for clearing airways: the cough. T In addition to decreasing the number of VAP cases by 50%, the company thinks its technology will also facilitate more use of noninvasive facemask ventilation, leading to an improvement in the quality of life for ICU patients.
Medical Device
See All

Company Information

  • Industry
  • Medical Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
  • Therapeutic Areas
  • Respiratory, Pulmonary
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Middle East
      • Israel
  • Parent & Subsidiaries
  • Innovent Medical Solutions Ltd.
  • Senior Management
  • Daniel Billig, CEO
    Eleizer Be'eri, MD, CSO
  • Contact Info
  • Innovent Medical Solutions Ltd.
    Phone: (972)
    19 Hartom St., 5th Fl.
    Bynet Bldg.
    Jerusalem, 91450